Cleared Special

DRSplus (K213705) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K213705 · Centervue S.P.A. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
27d
Days
Class 2
Risk

K213705 is an FDA 510(k) clearance for the DRSplus. Classified as Ophthalmoscope, Laser, Scanning (product code MYC), Class II - Special Controls.

Submitted by Centervue S.P.A. (Padova, IT). The FDA issued a Cleared decision on December 21, 2021 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Centervue S.P.A. devices

Submission Details

510(k) Number K213705 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2021
Decision Date December 21, 2021
Days to Decision 27 days
Submission Type Special
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 110d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MYC Ophthalmoscope, Laser, Scanning
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - MYC Ophthalmoscope, Laser, Scanning

Devices cleared under the same product code (MYC) and FDA review panel - the closest regulatory comparables to K213705.
OcuMet Beacon (OCUB100)
K241931 · Ocusciences, Inc. · Apr 2025
MAIA (AHMACME001)
K243504 · Centervue S.P.A. · Mar 2025
EIDON FA, EIDON, EIDON AF, EIDON UWFL
K211328 · Centervue S.P.A. · Aug 2021
DRSplus
K192113 · Centervue S.P.A. · Nov 2019
EIDON FA
K180526 · Centervue S.P.A. · Jul 2018
Retia 2
K180293 · Centervue S.P.A. · May 2018